Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Main Street Lending Program Waiting for Green Light from Congress – What We Know Now

Client Alert
April 17, 2020

What is the Main Street Lending Program?

In response to the COVID-19 pandemic, the Federal Reserve established the Main Street Lending Program (“MSLP”) to enhance support for small and mid-size businesses that were in good financial standing before the pandemic. There are two subcategories to the MSLP: the Main Street New Loan Facility (“MSNLF”), which applies to newly issued loans for a company, and the Main Street Expanded Loan Facility (“MSELF”), which applies to refinancing of existing loans of a company.

The main focus of MSLP is to retain employees (at least 90% of a business’s employees as of February 1, 2020). It is also intended to alleviate slow cash flow stress on profitable businesses.

Which businesses are eligible to apply? A business is an eligible borrower under the MSLP if it is organized in the U.S. or under U.S. laws; it has significant operations in the U.S.; a majority of its employees are based in the U.S.; and it employs 10,000 employees or less, or its 2019 annual revenues do not exceed $2.5 billion.

How much is a loan under MSLP?

  • The minimum loan size is $1 million. The maximum loan size depends on whether the borrower is seeking a MSNLF (new loan) or MSELF (refinance of a loan).  
  • The maximum allowable MSNLF loan is the lesser of (i) $25 million or (ii) an amount that, when added to the borrower’s existing outstanding and committed, but undrawn debt, does not exceed 4x the borrower’s 2019 earnings before interest, tax, depreciation and amortization (EBITDA); 
  • The maximum allowable MSELF loan is the lesser of $150 million, (ii) 30% of the borrower’s existing outstanding and committed but undrawn bank debt, or (iii) an amount that, when added to the borrower’s existing outstanding and committed but undrawn debt, does not exceed 6x the borrower’s 2019 EBITDA.

What is the loan term? The loan term is four years with interest and principal payments deferred for one year.

What is the interest rate on MSLP loans? Interest rate is an adjustable rate of SOFR plus 250-400 basis points.

Is there a fee associated with MSLP loans? Yes, but only for new loans (MSNLF). The borrower must pay the lender an original fee of 100 basis points on the principal of the loan.

Is collateral required? No, for new loans (MSNLF). It is up to the lender’s discretion for refinancing of existing loans (MSELF).

Is there a prepayment penalty? No.

Can a business apply for the MSLP after applying for and receiving a PPP loan? Yes, a business can receive funds from both MSLP and the PPP. But, unlike the PPP loan, no amount of the MSLP loan will be forgiven.  

What about the Primary Market Corporate Credit Facility (“PMCCF”)? No, a business cannot apply for MSLP and the PMCCF funds. It must pick one or the other. Also, a business cannot participate in both MSNLF and MSELF. It must pick one or the other.

How can a company use the MSLP funds? The funds received must be used to retain at least 90% of the borrower’s employees (based on numbers as of February 1, 2020). The borrower must use the funds to employee this 90% number of employees at full compensation and benefits through September 30, 2020. The released guidance does not elaborate on what this means. It simply states that the borrower will use reasonable efforts to restore not less than 90% of its workforce based on February 1, 2020 numbers and all compensation and benefits not later than four months after the emergency.

Are there any compliance issues or use limitations associated with MSLP loans? Yes, a business must make certain certifications/attestations when applying for a loan under MSLP.

There are compensation, stock repurchase, and dividend restrictions for businesses that receive MSLP loans. For example, a business cannot pay dividends or make other capital distributions with respect to common stock until one year after the loan is repaid. There are also several use limitations. For example, the business must commit to refrain from using MSLP funds to repay other loan balances. Also, a lender cannot reduce or cancel existing lines of credit and a borrower cannot seek to do so upon receipt of MSLP funds.

A business should discuss these restrictions with its attorney and lender before applying for the loan to make sure they can actually comply with the many restrictions associated with MSLP loans.

The Federal Reserve’s current term sheet for the MSNLF and MSELF  are found on its website. These terms are subject to change as final guidance is issued. The Federal Reserve received comments from industry leaders through April 15, 2020. Additional guidance is expected in the next few days.

For questions or more information, contact your primary BMD Attorney. 

MSNLFMSELFMain Street Lending Programmid-size businessessmall businessloansSBA LoansCassandra L. MannaBlake R. GerneyChristopher MeagerMSLPMain Street New Loan FacilityMain Street Expanded Loan Facility
Client Alert

Laboratory Specimen Collection Arrangements with Contract Hospitals - OIG Advisory Opinion 22-09

May 3, 2022On April 28, 2022, the Department of Health and Human Services, Office of Inspector General (“OIG”) published an Advisory Opinion[1] in which it evaluated a proposed arrangement where a network of clinical laboratories (the “Requestor”) would compensate hospitals (each a “Contract Hospital”) for specimen collection, processing, and handling services (“Collection Services”) for laboratory tests furnished by the Requestor (the “Proposed Arrangement”). The OIG concluded that the Proposed Arrangement would generate prohibited remuneration under the federal Anti-Kickback Statute (“AKS”) if the requisite intent were present. This is due to both the possibility that the proposed per-patient-encounter fee would be used to induce or reward referrals to Requestor and the associated risk of improperly steering patients to Requestor.Client Alert

Property Owner Protection from Tax Valuation Challenges

April 29, 2022New legislation provides significant new protections for commercial property owners against challenges to valuation primarily by local school boards and prohibiting side agreements to avoid tax valuation changes. The Ohio Legislature has approved House Bill 126 which will go into effect July 2022 but will effectively apply to the 2023 tax valuation year.Client Alert

No Surprises Act Update: The IDR Portal is Open

April 25, 2022The No Surprises Act (“NSA”) became effective January 1, 2022, and has been the subject of lawsuits and criticisms since its inception. The goals of the No Surprises Act are to shield patients from surprise medical bills, provide to uninsured and self-pay patients good faith estimates of charges, and create a process to resolve payment disputes over surprise bills, which arise most typically in emergency care settings. We have written about Part I and Part II of the NSA previously. This update concerns the Independent Dispute Resolution (“IDR”) procedure created by Part II but applicable to claims covered by Part I. The Centers for Medicare & Medicaid Services (“CMS”) finally opened the Portal for providers to submit disputes to the IDR process following some updated guidance regarding the arbitration process itself.Client Alert

Updated FAQs for the No Surprises Act - Good Faith Estimates

April 7, 2022The No Surprises Act (“NSA”) became effective January 1, 2022. Meant to protect consumers from surprise medical bills, the new law is good for consumers, but vexatious for health care providers and facilities. One particular source of frustration is the operationalization of the Good Faith Estimate (“GFE”) requirement, governed by Part II of the regulations that implement the NSA. The GFE requirements apply broadly to all healthcare providers and facilities that practice within the scope of their state-issued license.Client Alert

IMPORTANT PRF UPDATE! HRSA Allows Providers the Opportunity to Correct Missed Period 1 Reporting

April 7, 2022Late Wednesday, April 6, HRSA announced that it was going to allow providers with extenuating circumstances that prevented them from preventing a completed Period 1 Report to submit a Request to Report Late Due to Extenuating Circumstances.
Older posts
Newer posts